InvestorsHub Logo
Followers 135
Posts 13914
Boards Moderated 0
Alias Born 09/05/2013

Re: None

Monday, 06/28/2021 12:33:04 PM

Monday, June 28, 2021 12:33:04 PM

Post# of 22000
"Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects":
19 June 2021

Highlights
-Both cannabidiol and ketamine promote antidepressant-like effect dependent on AMPA receptor activation.

-Pre-administration of cannabidiol did not induce effects per se in the open field test but prevented ketamine-induced hyperlocomotion.

-Cannabidiol prevented ketamine-induced hyperlocomotion while preserving its antidepressant effect.

-Cannabidiol holds potential therapeutic benefit as add-on therapy to ketamine to prevent its side-effects.


https://www.sciencedirect.com/science/article/pii/S0028390821002343
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CWBHF News